Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fast pneumonia test could save ICU patients from wrong antibiotics

NCT ID NCT06478953

Diagnosis Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a rapid diagnostic test (BioFire Pneumonia Panel) in 40 ICU patients on ventilators with suspected pneumonia. Half got the rapid test, half got standard care. The goal was to see if the test helps doctors give the right antibiotics sooner. Results could lead to better treatment and less antibiotic resistance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BioFire FilmArray Pneumonia Panel (diagnostic test)
What this could lead to
If successful, this rapid test could help doctors choose the right antibiotics faster for ICU patients with pneumonia, potentially improving outcomes and reducing antibiotic overuse.
What could go wrong
This is a small pilot study with only 40 patients, so results may not apply broadly. The test may not always be accurate or change treatment as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

40 people

The number who actually took part.

Started

Jun 2024

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * adult (≥18 years old) ICU patients * mechanical ventilation * new antibiotic prescription within 24 hours for suspected community acquired, healthcare or ventilator associated pneumonia * suspected pneumonia is defined as any of purulent sputum, cough, fever, shortness of breath, hypoxia, hypercapnia or abnormal white cell count AND chest infiltrates on imaging * need for antibiotics other than suspected respiratory infection * aspiration pneumonia * suspected pneumonia due to tuberculosis * known respiratory pathogens within 7 days prior to randomization * given empirical antimicrobials for suspected Stenotrophomonas infection * lack of sufficient respiratory samples for culture and FA Pneumonia Panel * not expected to survive beyond 48 hours * limitation of therapy prior to recruitment * prisoners * allergy to antibiotics * immunosuppression from long term steroid of at least 5 mg/day or chemotherapy or HIV or haematological disease * pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Critically ill are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Critical Illness Infections pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Critically ill Pneumonia

Contacts and locations

Locations

  • Prince of Wales Hospital

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.